Find publications by Adaptive as well as our collaborators and partners who leverage our technologies.



Radiotherapy induces responses of lung cancer to CTLA-4 blockade

Formenti et al.

  • Nature Medicine
  • December 2018

Tumour associated lymphocytes in the pleural effusions of patients with mesothelioma express high levels of inhibitory receptors

Chee et al.

  • BMC Research Notes
  • December 2018

MMP-9 inhibition promotes anti-tumor immunity through disruption of biochemical and physical barriers to T-cell trafficking to tumors

Juric et al.

  • November 2018

Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma

Blank et al.

  • Nature Medicine
  • November 2018

PEGylated IL-10 (Pegilodecakin) Induces Systemic Immune Activation, CD8+ T Cell Invigoration and Polyclonal T Cell Expansion in Cancer Patients

Naing et al.

  • Cancer Cell
  • November 2018

Neoadjuvant ipilimumab (3 mg/kg or 10 mg/kg) and high dose IFN-α2b in locally/regionally advanced melanoma: safety, efficacy and impact on T-cell repertoire

Tarhini et al.

  • Journal for ImmunoTherapy of Cancer
  • October 2018

Neoantigenic Potential of Complex Chromosomal Rearrangements in Mesothelioma

Mansfield et al.

  • Journal of Thoracic Oncology
  • October 2018

Enhanced detection of neoantigen-reactive T cells targeting unique and shared oncogenes for personalized cancer immunotherapy

Yossef et al.

  • JCI Insight
  • October 2018

Autologous iPSC-Based Vaccines Elicit Anti-tumor Responses In Vivo

Kooreman et al.

  • Cell Stem Cell
  • Papers
  • April 2018